Diskussion zu BrainChip Holdings (Seite 1527)
eröffnet am 31.10.17 03:14:28 von
neuester Beitrag 09.05.24 21:44:35 von
neuester Beitrag 09.05.24 21:44:35 von
Beiträge: 15.565
ID: 1.265.618
ID: 1.265.618
Aufrufe heute: 497
Gesamt: 754.164
Gesamt: 754.164
Aktive User: 4
ISIN: AU000000BRN8 · WKN: A14Z7W · Symbol: 24Y
0,1661
EUR
-4,98 %
-0,0087 EUR
Letzter Kurs 20:02:02 Tradegate
Neuigkeiten
08.05.24 · Business Wire (engl.) |
06.05.24 · Business Wire (engl.) |
06.05.24 · Business Wire (engl.) |
05.05.24 · Business Wire (engl.) |
Werte aus der Branche Informationstechnologie
Wertpapier | Kurs | Perf. % |
---|---|---|
1,0000 | +99.999,00 | |
52,10 | +323,58 | |
12,350 | +257,97 | |
0,5500 | +161,90 | |
5,2550 | +126,51 |
Wertpapier | Kurs | Perf. % |
---|---|---|
171,15 | -26,20 | |
9.751,50 | -29,84 | |
1,1600 | -29,91 | |
8,5980 | -36,69 | |
5,2000 | -39,53 |
Beitrag zu dieser Diskussion schreiben
Financial Year 2020 Outlook:
Akida Intellectual Property licensing is expected based on current customer engagements. IP
licensing can precede Akida device sales by several quarters as no manufacturing cycle is
required, the licenses will be pre-paid and the IP is well documented. IP licenses represent
significant gross margin and operating margin and can add support for the Company’s cash
requirements in 2020.
Akida Device design wins can be established on engineering samples. OEM customers design
cycles are variable and are dependent on end-market. Consumer applications are typically
six to nine months, while industrial and automotive applications can be several years.
The Company is evaluating opening two Innovation Centers in 2020. The first in Western
Australia where the Company has significant historical presence and there is a talented
engineering community that can support Advanced Research as well as regional customer
activity. The second in Shanghai, China to support the large and growing AI Edge market in
the region.
Akida Intellectual Property licensing is expected based on current customer engagements. IP
licensing can precede Akida device sales by several quarters as no manufacturing cycle is
required, the licenses will be pre-paid and the IP is well documented. IP licenses represent
significant gross margin and operating margin and can add support for the Company’s cash
requirements in 2020.
Akida Device design wins can be established on engineering samples. OEM customers design
cycles are variable and are dependent on end-market. Consumer applications are typically
six to nine months, while industrial and automotive applications can be several years.
The Company is evaluating opening two Innovation Centers in 2020. The first in Western
Australia where the Company has significant historical presence and there is a talented
engineering community that can support Advanced Research as well as regional customer
activity. The second in Shanghai, China to support the large and growing AI Edge market in
the region.
Sehr vielversprechend 👍👍👍
Antwort auf Beitrag Nr.: 62.090.951 von H2OAllergiker am 05.12.19 20:34:36Danke fürs Einstellen ;-)
08.05.24 · Business Wire (engl.) · BrainChip Holdings |
06.05.24 · Business Wire (engl.) · BrainChip Holdings |
06.05.24 · Business Wire (engl.) · BrainChip Holdings |
05.05.24 · Business Wire (engl.) · BrainChip Holdings |
30.04.24 · Business Wire (engl.) · BrainChip Holdings |
24.04.24 · wO Chartvergleich · Bayer |
18.04.24 · Business Wire (engl.) · BrainChip Holdings |
11.04.24 · Business Wire (engl.) · BrainChip Holdings |
23.03.24 · wallstreetONLINE Redaktion · Advanced Micro Devices |
14.03.24 · Business Wire (engl.) · BrainChip Holdings |